Adicet Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Adicet Bio and other ETFs, options, and stocks.

About ACET

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. 

CEO
Chen Schor
CEOChen Schor
Employees
152
Employees152
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2014
Founded2014
Employees
152
Employees152

ACET Key Statistics

Market cap
54.79M
Market cap54.79M
Price-Earnings ratio
-0.51
Price-Earnings ratio-0.51
Dividend yield
Dividend yield
Average volume
333.51K
Average volume333.51K
High today
$0.68
High today$0.68
Low today
$0.642
Low today$0.642
Open price
$0.67
Open price$0.67
Volume
359.44K
Volume359.44K
52 Week high
$1.70
52 Week high$1.70
52 Week low
$0.4471
52 Week low$0.4471

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own ACET. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.